Genmab — Marts 2024
-
Novo har lige fremhævet Mim8. At det er en prioritet at maximize Mim8 muligheden
-
https://www.morningstar.com/company-reports/1211878-genmab-strong-royalty-revenue-from-darzalex-provides-ample-cash-flow-shares-undervalued?listing=0P0000A5QU morningstar maintains fair value target of 2650
-
-
Det må være i tilknytning til deres nuværende lokation i NJ https://www.colliers.com/en/properties/class-a-building-in-corporate-campus-setting/usa-777-scudders-mill-road-plainsboro-new-jersey-08536/usa1037869
-
https://www.novonordisk.com/content/dam/nncorp/global/en/investors/pdfs/capital-markets-day-2022/P6-rare-disease.pdf follwoing troldmanden comment this morning, Novo capital-markets-day rare-disease presentation
-
-
Hvor meget af mim8 har Genmab? Det kan jeg umiddelbart ikke se på hjemmesiden.
-
Tak Bulder.
-
Mener vi plejer at tale om 8%, men må slå det op
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind